Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bohgaki

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Modern Rheumatology|January 7, 2014
Vasculitis following implantation of a ventriculoperitoneal shunt tube made of siliconeM Bohgaki, M Mukai, A Notoya, et al.
Thrombosis Research|March 15, 1990
Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysisK Wanaka, S Okamoto, M Bohgaki, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Complement activation in patients with primary antiphospholipid syndromeK Oku, T Atsumi, M Bohgaki, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Highly selective synthetic inhibitors with regard to plasma-kallikrein activitiesS Okamoto, U Okamoto, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1989
Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikreinY Tsuda, N Teno, Y Okada, et al.
Thrombosis Research|April 1, 1996
Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actionsK Wanaka, S Okamoto, N Horie, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisT Bohgaki, Y Amasaki, N Nishimura, et al.
Cell Death and Differentiation|March 2, 2013
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnoverM Bohgaki, A Hakem, M J Halaby, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Modern Rheumatology|January 7, 2014
Vasculitis following implantation of a ventriculoperitoneal shunt tube made of siliconeM Bohgaki, M Mukai, A Notoya, et al.
Thrombosis Research|March 15, 1990
Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysisK Wanaka, S Okamoto, M Bohgaki, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Complement activation in patients with primary antiphospholipid syndromeK Oku, T Atsumi, M Bohgaki, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Highly selective synthetic inhibitors with regard to plasma-kallikrein activitiesS Okamoto, U Okamoto, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1989
Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikreinY Tsuda, N Teno, Y Okada, et al.
Thrombosis Research|April 1, 1996
Use of an active center-directed plasmin inhibitor elucidates the multiplicity of plasmin actionsK Wanaka, S Okamoto, N Horie, et al.
Annals of the Rheumatic Diseases|July 15, 2005
Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisT Bohgaki, Y Amasaki, N Nishimura, et al.
Cell Death and Differentiation|March 2, 2013
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnoverM Bohgaki, A Hakem, M J Halaby, et al.
Pageof 1